<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Experimental Drugs Show Promise for Containing Ebola Outbreak
Image Overlay - Experimental Drugs Show Promise for Containing Ebola Outbreak

Experimental Drugs Show Promise for Containing Ebola Outbreak

August 28, 2019

Experimental Drugs Show Promise for Containing Ebola Outbreak

Two experimental Ebola treatments — Regeneron's REGN-EB3 and another antibody-based therapy called mAb114 — are advancing to an extension phase of a large clinical trial after an it was determined they offer significantly better survival rates than the standard of care. Yourway is pleased with this clinical progress, having assisted Regeneron in rapidly delivering experimental Ebola drugs to infected patients in the Congo during the 2018 outbreak.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Media

Articles

White-Glove by Design: The Yourway Standard in Clinical Logistics

Open chat
Come chat with us!
Hello! How can I help you?